Current and new pharmacotherapy options for non-alcoholic steatohepatitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current and new pharmacotherapy options for non-alcoholic steatohepatitis

Published:2020-04-01 Issue:8 Volume:21 Page:953-967
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Sumida Yoshio¹,Yoneda Masato²,Ogawa Yuji²,Yoneda Masashi¹,Okanoue Takeshi³,Nakajima Atsushi²

Affiliation:

1. Division of Hepatology and Pancreatology, Department of Internal Medicine, Aichi Medical University, Kasugai, Japan

2. Department of Gastroenterology and Hepatology, Yokohama City University, Yokohama, Japan

3. Department of Gastroenterology, Suita Hospital, Osaka, Japan

Funder

not funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2020.1744564

Reference124 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

2. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study

3. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation

4. Causes of death in Japanese patients with diabetes based on the results of a survey of 45,708 cases during 2001-2010: Report of the Committee on Causes of Death in Diabetes Mellitus

5. Metabolic aspects of adult patients with nonalcoholic fatty liver disease

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. l-Ornithine-l-Aspartate (LOLA) Normalizes Metabolic Parameters in Models of Steatosis, Insulin Resistance and Metabolic Syndrome;Pharmaceutics;2024-04-07

2. Emerging drugs for the treatment of hepatic fibrosis on nonalcoholic steatohepatitis;Expert Opinion on Emerging Drugs;2024-03-25

3. IAVPGEVA: Orally Available DPP4-Targeting Soy Glycinin Derived Octapeptide with Therapeutic Potential in Nonalcoholic Steatohepatitis;Journal of Agricultural and Food Chemistry;2024-03-21

4. Liver sinusoidal cells in the diagnosis and treatment of liver diseases: Role of hepatic stellate cells;Sinusoidal Cells in Liver Diseases;2024

5. A revisit of drugs and potential therapeutic targets against non-alcoholic fatty liver disease: learning from clinical trials;Journal of Endocrinological Investigation;2023-10-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3